lactic acid has been researched along with montelukast in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ahmed, TA; Hussain, MD; Ibrahim, HM; Kaseem, A; Nutan, MT; Samy, AM | 1 |
| Ahsan, F; Gupta, N; Patel, B | 1 |
| Mhaisalkar, PS; Prabhakaran, MP; Ramakrishna, S; Varshosaz, J; Zamani, M | 1 |
| Ahsan, F; Patel, B; Rashid, J | 1 |
5 other study(ies) available for lactic acid and montelukast
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability.
Topics: Absorbable Implants; Acetates; Animals; Chemistry, Pharmaceutical; Cyclopropanes; Dimethyl Sulfoxide; Drug Implants; Drug Stability; Injections, Intramuscular; Lactic Acid; Leukotriene Antagonists; Male; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Quinolines; Rats, Sprague-Dawley; Solubility; Solvents; Sulfides; Technology, Pharmaceutical; Temperature; Triacetin | 2014 |
Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model.
Topics: Acetates; Aerosols; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Disease Models, Animal; Inflammation; L-Lactate Dehydrogenase; Lactic Acid; Leukotrienes; Lung; Ovalbumin; Peroxidase; Polyesters; Polymers; Quinolines; Rats; Rats, Sprague-Dawley; Sulfides | 2014 |
Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis.
Topics: Acetates; Calorimetry, Differential Scanning; Cell Count; Cell Movement; Cell Proliferation; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Vessels; Cyclopropanes; Drug Liberation; Endothelial Cells; Flow Cytometry; Humans; Lactic Acid; Myocytes, Smooth Muscle; Phenotype; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quinolines; Receptors, Leukotriene; Stents; Sulfides | 2016 |
Aerosolizable modified-release particles of montelukast improve retention and availability of the drug in the lungs.
Topics: Acetates; Administration, Inhalation; Animals; Anti-Asthmatic Agents; Asthma; Biological Availability; Bronchoalveolar Lavage Fluid; Cyclopropanes; Drug Carriers; Humans; Lactic Acid; Lung; Macrophages, Alveolar; Male; Particle Size; Polyethyleneimine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Quinolines; Rats; Rats, Sprague-Dawley; Sulfides | 2017 |